Literature DB >> 30274611

Paravalvular Regurgitation After Transcatheter Aortic Valve Replacement: Is the Problem Solved?

Géraldine Ong1, Mohammed-Salah Annabi1, Marie-Annick Clavel1, Ezequiel Guzzetti1, Erwan Salaun1, Oumhani Toubal1, Abdellaziz Dahou1, Philippe Pibarot2.   

Abstract

Paravalvular regurgitation is a frequent complication after transcatheter aortic valve replacement and its association with worse outcomes depends on the degree of its severity. Despite substantial improvement in transcatheter heart valve design, sizing and implantation technique, moderate or severe paravalvular regurgitation still occurs in 2% to 7% of patients and is associated with a more than 2-fold increase in mortality. This review provides a state-of-the-art approach to (i) paravalvular regurgitation prevention by optimizing patient selection, valve sizing, and positioning and (ii) the detection, quantitation and management of paravalvular regurgitation during and after valve implantation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic stenosis; Complication; Paravalvular aortic regurgitation; Transcatheter aortic valve replacement; Valve implantation

Mesh:

Substances:

Year:  2018        PMID: 30274611     DOI: 10.1016/j.iccl.2018.06.005

Source DB:  PubMed          Journal:  Interv Cardiol Clin        ISSN: 2211-7458


  2 in total

1.  Mixed Valvular Disease Following Transcatheter Aortic Valve Replacement: Quantification and Systematic Differentiation Using Clinical Measurements and Image-Based Patient-Specific In Silico Modeling.

Authors:  Zahra Keshavarz-Motamed; Seyedvahid Khodaei; Farhad Rikhtegar Nezami; Junedh M Amrute; Suk Joon Lee; Jonathan Brown; Eyal Ben-Assa; Tamara Garcia Camarero; Javier Ruano Calvo; Stephanie Sellers; Philipp Blanke; Jonathon Leipsic; Jose M de la Torre Hernandez; Elazer R Edelman
Journal:  J Am Heart Assoc       Date:  2020-02-28       Impact factor: 5.501

2.  Minimizing Paravalvular Regurgitation With the Novel SAPIEN 3 Ultra TAVR Prosthesis: A Real-World Comparison Study.

Authors:  Alexander R Tamm; Michaela M Hell; Martin Geyer; Felix Kreidel; Jaqueline G da Rocha E Silva; Meike Seidl; Tobias F Ruf; Angela Kornberger; Andres Beiras-Fernandez; Thomas Münzel; Ralph Stephan von Bardeleben
Journal:  Front Cardiovasc Med       Date:  2021-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.